{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:50:35Z","timestamp":1788468635585,"version":"build-2803163510"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jconrel.2022.08.021","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T10:54:39Z","timestamp":1661511279000},"page":"308-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Advanced formulations and nanotechnology-based approaches for pulmonary delivery of sildenafil: A scoping review"],"prefix":"10.1016","volume":"350","author":[{"given":"Raul Edison Luna","family":"Lazo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Mengarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana Le\u00e3o","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Caldonazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel Toribio","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio Seigi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.08.021_bb0005","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0010","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","article-title":"Pediatric pulmonary hypertension","volume":"132","author":"Abman","year":"2015","journal-title":"Circulation."},{"issue":"2016","key":"10.1016\/j.jconrel.2022.08.021_bb0015","first-page":"67","article-title":"ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"37","author":"Gali\u00e8","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jconrel.2015.05.287","article-title":"Novel therapeutic approaches for pulmonary arterial hypertension: unique molecular targets to site-specific drug delivery","volume":"211","author":"Vaidya","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0025","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3109\/10837450.2015.1086369","article-title":"Inhaled sildenafil nanocomposites: lung accumulation and pulmonary pharmacokinetics*","volume":"21","author":"Ghasemian","year":"2016","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0030","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/CIRCRESAHA.107.162511","article-title":"Phosphodiesterase type 5: expanding roles in cardiovascular regulation","volume":"101","author":"Kass","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jconrel.2017.02.003","article-title":"Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH)","volume":"250","author":"Rashid","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0040","first-page":"181","article-title":"Carrier free dry powder formulation of sildenafil for potential application in pulmonary arterial hypertension","volume":"71","author":"Ghanbarzadeh","year":"2016","journal-title":"Pharmazie."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.sxmr.2018.06.005","article-title":"The serendipitous story of sildenafil: an unexpected Oral therapy for erectile dysfunction","volume":"7","author":"Goldstein","year":"2019","journal-title":"Sexual Med. Rev."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0050","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrd2030","article-title":"Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond","volume":"5","author":"Ghofrani","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0055","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","article-title":"Oral sildenafil in the treatment of erectile dysfuntion. Sildenafil study group","volume":"338","author":"Rwin","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0060","series-title":"Viagra (sildenafil) approval letter","author":"Food and Drug Administration (FDA)","year":"1998"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0065","author":"European Medicines Agency (EMA)"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0070","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Gali\u00e8","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0075","author":"European Medicines Agency (EMA)"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0080","author":"Food and Drug Administration (FDA)"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0085","series-title":"Revatio (sildenafil) Injection approval letter","author":"Food and Drug Admnistration (FDA)","year":"2009"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0090","first-page":"68","article-title":"Preparation, characterization and optimization of sildenafil citrate loaded PLGA nanoparticles by statistical factorial design, DARU","volume":"21","author":"Ghasemian","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0095","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1208\/s12249-018-0982-7","article-title":"Biowaiver or bioequivalence: ambiguity in sildenafil citrate BCS classification","volume":"19","author":"Miranda","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0100","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12272-011-0313-y","article-title":"Comparison of the solubility and pharmacokinetics of sildenafil salts","volume":"34","author":"Jung","year":"2011","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0105","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jsps.2015.01.019","article-title":"Why sildenafil and sildenafil citrate monohydrate crystals are not stable?","volume":"23","author":"Sawatdee","year":"2015","journal-title":"Saudi Pharmaceut. J."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0110","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3109\/10837450.2015.1098661","article-title":"Formulation and process considerations for the design of sildenafil-loaded polymeric microparticles by vibrational spray-drying","volume":"22","author":"Beck-Broichsitter","year":"2017","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0115","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jconrel.2011.10.030","article-title":"Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery","volume":"158","author":"Beck-Broichsitter","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0120","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/jphp.12434","article-title":"Characterization of lung-delivered in-situ forming controlled release formulations","volume":"67","author":"Dalla-Bona","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0125","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijpharm.2013.07.023","article-title":"Sildenafil citrate monohydrate-cyclodextrin nanosuspension complexes for use in metered-dose inhalers","volume":"455","author":"Sawatdee","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijpharm.2014.09.031","article-title":"Physicochemical characterization of sildenafil-loaded solid lipid nanoparticle dispersions (SLN) for pulmonary application","volume":"476","author":"Paranjpe","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0135","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s13346-018-0586-5","article-title":"Formulation and evaluation of carrier-free dry powder inhaler containing sildenafil","volume":"9","author":"Nguyen","year":"2019","journal-title":"Drug Delivery Translat. Res."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5530\/ijpi.2020.1.17","article-title":"View of development of spray-dried sildenafil citrate -\u03b1-cyclodextrin complexes for use in dry powder inhalers","volume":"10","author":"Atiparin","year":"2020","journal-title":"Int. J. Pharm. Invest."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0145","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3390\/app8081291","article-title":"Sildenafil citrate liposomes for pulmonary delivery by ultrasonic nebulization","volume":"8","author":"de Jesus Valle","year":"2018","journal-title":"Appl. Sci Basel"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0150","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2019.03.029","article-title":"Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension","volume":"302","author":"Shahin","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0155","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jconrel.2011.09.058","article-title":"Development of a biodegradable nanoparticle platform for sildenafil: formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters","volume":"157","author":"Beck-Broichsitter","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0160","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijpharm.2016.12.026","article-title":"Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5-inhibitor","volume":"517","author":"Makled","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0165","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3109\/01902148.2015.1064492","article-title":"Preclinical safety evaluation of submicronized sildenafil citrate nebulization solution in small experimental animals","volume":"41","author":"Agrawal","year":"2015","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2018.11.004","article-title":"Insight into pulmonary drug delivery: mechanism of drug deposition to device characterization and regulatory requirements","volume":"54","author":"Rangaraj","year":"2019","journal-title":"Pulmon. Pharmacol. Therapeut."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0175","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1080\/10837450.2019.1650766","article-title":"Development of nanodispersion-based sildenafil metered-dose inhalers stabilized by poloxamer 188: a potential candidate for the treatment of pulmonary arterial hypertension","volume":"24","author":"Chunhachaichana","year":"2019","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0180","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3109\/08958378.2013.810315","article-title":"In vitro and ex vivo toxicological testing of sildenafil-loaded solid lipid nanoparticles","volume":"25","author":"Paranjpe","year":"2013","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejps.2018.10.003","article-title":"Nanostructured lipid carriers versus solid lipid nanoparticles for the potential treatment of pulmonary hypertension via nebulization","volume":"125","author":"Nafee","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120320","article-title":"Formulation and optimization of sildenafil citrate-loaded PLGA large porous microparticles using spray freeze-drying technique: a factorial design and in-vivo pharmacokinetic study","volume":"597","author":"Shahin","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0195","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/oem.37.4.337","article-title":"Deposition, retention, and clearance of inhaled particles","volume":"37","author":"Lippmann","year":"1980","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0200","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/jamp.2017.1382","article-title":"Critical parameters for particle-based pulmonary delivery of chemotherapeutics","volume":"31","author":"Dabbagh","year":"2018","journal-title":"J Aerosol Med. Pulmon. Drug Delivery."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0205","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jconrel.2020.07.002","article-title":"Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases","volume":"325","author":"Douafer","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0210","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/aps.2017.34","article-title":"Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities","volume":"38","author":"Mangal","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0215","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.2174\/1381612821666150820111134","article-title":"Powder production and particle engineering for dry powder inhaler formulations","volume":"21","author":"Lin","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0220","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/2230-973X.108959","article-title":"Exploring targeted pulmonary delivery for treatment of lung cancer","volume":"3","author":"Goel","year":"2013","journal-title":"Int. J. Pharmaceut Invest."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0225","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jconrel.2017.11.036","article-title":"Inhalable particulate drug delivery systems for lung cancer therapy: nanoparticles, microparticles, nanocomposites and nanoaggregates","volume":"269","author":"Abdelaziz","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0230","first-page":"1346","article-title":"Determinants of patient adherence to an aerosol regimen","volume":"50","author":"Rau","year":"2005","journal-title":"Respir. Care"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0235","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0140-6736(10)60926-9","article-title":"Aerosol drug delivery: developments in device design and clinical use","volume":"377","author":"Dolovich","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0240","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1152\/japplphysiol.00440.2018","article-title":"Sex differences in large conducting airway anatomy","volume":"125","author":"Dominelli","year":"2018","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0245","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2020.07.006","article-title":"Emerging trends in inhaled drug delivery","volume":"157","author":"Hickey","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1753466619835497","article-title":"Lloprost delivered via the BREELIBTM nebulizer: a review of the clinical evidence for efficacy and safety","volume":"13","author":"Gessler","year":"2019","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0255","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4187\/respcare.03927","article-title":"Inhaled therapies for pulmonary hypertension","volume":"60","author":"Hill","year":"2015","journal-title":"Respir. Care"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0260","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/XEB.0000000000000050","article-title":"Guidance for conducting systematic scoping reviews","volume":"13","author":"Peters","year":"2015","journal-title":"Int. J Evidence-Based Healthcare."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0265","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0270","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00003246-200105000-00024","article-title":"Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension","volume":"29","author":"Ichinose","year":"2001","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0275","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ijpharm.2011.10.012","article-title":"Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb\u00ae pro: formulation aspects and nanoparticle stability to nebulization","volume":"422","author":"Beck-Broichsitter","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2016.01.057","article-title":"Potential of the isolated lung technique for the examination of sildenafil absorption from lung-delivered poly(lactide- co -glycolide) microparticles","volume":"226","author":"Beck-Broichsitter","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0285","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jconrel.2020.01.028","article-title":"Polyester based polymeric nano and microparticles for pharmaceutical purposes: a review on formulation approaches","volume":"320","author":"Molavi","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0290","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.2042-7158.2012.01486.x","article-title":"Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises","volume":"64","author":"Ungaro","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0295","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.nano.2015.08.009","article-title":"Prolonged vasodilatory response to nanoencapsulated sildenafil in pulmonary hypertension","volume":"12","author":"Beck-Broichsitter","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0300","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nmat2608","article-title":"Porous metal-organic-framework nanoscale carriers as a potential platform for drug deliveryand imaging","volume":"9","author":"Horcajada","year":"2010","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0305","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2052520613029557","article-title":"Crystalline metal-organic frameworks (MOFs): synthesis, structure and function","volume":"70","author":"Dey","year":"2014","journal-title":"Acta Crystallogr. Sect. B: Struct. Sci. Cryst. Eng. Mater."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0310","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1038\/s41598-021-83423-6","article-title":"Studies on metal\u2013organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension","volume":"11","author":"Mohamed","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0315","first-page":"90","article-title":"Evaluation of sildenafil pressurized metered dose inhalers as a vasodilator in umbilical blood vessels of chicken egg embryos","volume":"86","author":"Sawatdee","year":"2014","journal-title":"Eur. J Pharmaceut. Biopharmaceut. Off. J. Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0320","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/ejlt.201300406","article-title":"Toxicity testing of sildenafil base-loaded liposomes in in vitro and ex vivo models for pulmonary application","volume":"116","author":"Paranjpe","year":"2014","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0325","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ejmech.2019.01.007","article-title":"Composition design and medical application of liposomes","volume":"164","author":"Li","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmolb.2020.587997","article-title":"Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects","volume":"7","author":"Scioli Montoto","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0335","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0340","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.powtec.2015.08.033","article-title":"Direct fractionation of spray-dried polymeric microparticles by inertial impaction","volume":"286","author":"Beck-Broichsitter","year":"2015","journal-title":"Powder Technol."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0345","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejpb.2015.03.001","article-title":"Modified vibrating-mesh nozzles for advanced spray-drying applications","volume":"92","author":"Beck-Broichsitter","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0350","doi-asserted-by":"crossref","DOI":"10.1002\/ppsc.202000251","article-title":"Nano-in-micro sildenafil dry powder formulations for the treatment of pulmonary arterial hypertension disorders: the synergic effect of POxylated Polyurea dendrimers, PLGA, and cholesterol","volume":"37","author":"Restani","year":"2020","journal-title":"Part. Part. Syst. Charact."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0355","doi-asserted-by":"crossref","first-page":"L119","DOI":"10.1152\/ajplung.00381.2018","article-title":"Inhaled combination of sildenafil and rosiglitazone improves pulmonary hemodynamics, cardiac function, and arterial remodeling","volume":"316","author":"Rashid","year":"2019","journal-title":"Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.671381","article-title":"A pathway from porous particle technology toward tailoring aerogels for pulmonary drug administration","volume":"9","author":"Duong","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0365","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1126\/science.276.5320.1868","article-title":"Large porous particles for pulmonary drug delivery","volume":"276","author":"Edwards","year":"1997","journal-title":"Science."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0370","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2174\/1381612822666160128145356","article-title":"Large porous hollow particles: lightweight champions of pulmonary drug delivery","volume":"22","author":"Gharse","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0375","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejps.2017.05.007","article-title":"Large porous particles for respiratory drug delivery. Glycine-based formulations","volume":"110","author":"Ogienko","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0380","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4155\/tde.11.100","article-title":"Pulmonary delivery of inhalable nanoparticles: dry powder inhalers","volume":"2","author":"Al-Hallak","year":"2011","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0385","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.apsb.2016.03.011","article-title":"Influence of physical properties of carrier on the performance of dry powder inhalers","volume":"6","author":"Peng","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0390","first-page":"519","article-title":"Physicochemical analysis techniques specialized in surface characterization of inhalable dry powders","volume":"51","author":"Park","year":"2021"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0395","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2014.11.035","article-title":"In vitro dry powder inhaler formulation performance considerations","volume":"199","author":"Ziffels","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0400","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jconrel.2014.03.052","article-title":"Hydrogels in a historical perspective: from simple networks to smart materials","volume":"190","author":"Buwalda","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0405","first-page":"2732017","article-title":"Inhaled therapy in respiratory disease: the complex interplay of pulmonary kinetic processes","volume":"2018","author":"Borghardt","year":"2018","journal-title":"Can. Respir. J."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0410","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-2125.2003.01893.x","article-title":"Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications","volume":"56","author":"Labiris","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2045894020985345","article-title":"Impact of human behavior on inspiratory flow profiles in patients with pulmonary arterial hypertension using AOSTM dry powder inhaler device","volume":"11","author":"Sahay","year":"2021","journal-title":"Pulmon. Circulat."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2022.864922","article-title":"Evaluation and selection of the inhaler device for Treprostinil Palmitil inhalation powder","volume":"2","author":"Gauani","year":"2022","journal-title":"Front. Drug Delivery."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0425","series-title":"Tyvaso DPI (Teprostinil) aproval letter","author":"Food and Drug Administration (FDA)","year":"2022"},{"key":"10.1016\/j.jconrel.2022.08.021_bb0430","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/17425247.2020.1729119","article-title":"Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension","volume":"17","author":"Keshavarz","year":"2020","journal-title":"Expert Opin. Drug Delivery."},{"key":"10.1016\/j.jconrel.2022.08.021_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114173","article-title":"Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient?","volume":"183","author":"Forest","year":"2022","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:30:52Z","timestamp":1759163452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922005260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":87,"alternative-id":["S0168365922005260"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.021","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced formulations and nanotechnology-based approaches for pulmonary delivery of sildenafil: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}